Viewing nowPuringsami Tablet (Phendimetrazine Tartrate)
Phendimetrazine Tartrate 17.5mg
Tablet · Prescription medication
Alvogen Korea Co., Ltd.

MFDS item code 201604676 · Approved 2016.07.28
Short-term weight loss adjunctive therapy for obesity (high body mass index and risk factors)
This medication is used for obese patients with a body mass index (BMI) of 30 or more, or with risk factors such as hypertension, diabetes, or hyperlipidemia, who find it difficult to lose weight with appropriate dietary and exercise regimens. It serves as a short-term adjunctive therapy, providing assistance while following a calorie-restricted diet for weight loss. This medication should be taken alone and not in combination with other appetite suppressants for safety. Therefore, it aids in effective weight management for obese patients and contributes to health improvement.
As phendimetrazine tartrate, take 35 mg orally 2 to 3 times a day one hour before meals. Use the minimum effective dose and adjust individually to obtain an adequate response. For some patients, a single dose of 17.5 mg per day may be appropriate. The total dosage should not exceed 70 mg per dose or 3 doses per day. This medication is administered for a short duration (within 4 weeks).
This medication should not be taken together with other appetite suppressants as it may cause serious heart problems. It must be used alone and only for a short duration when treating exogenous obesity. Long-term use beyond three months should be avoided, as it may increase the risk of rare heart conditions like pulmonary arterial hypertension. If shortness of breath, chest pain, fainting, or leg swelling occurs during exercise, the medication must be stopped immediately and a doctor should be consulted. Individuals with heart diseases such as valve heart disease or those with heart murmurs should refrain from using this medication. It is necessary to confirm the existence of any pre-existing heart conditions through heart tests prior to using this drug. Persons sensitive to sympathomimetic agents, those with cardiovascular diseases, hyperthyroidism, glaucoma, or those who are mentally anxious or agitated, as well as individuals with a history of substance abuse, should not take this medication. It should also not be administered to patients currently on other central nervous system stimulants or MAO inhibitors. Children under 16 years of age and women who are pregnant or may become pregnant should also avoid this medication. Caution is required for patients with mild hypertension, breastfeeding mothers, and diabetic patients when using this medication. This drug may cause side effects such as increased heart rate or elevated blood pressure, and central nervous system symptoms like anxiety, dizziness, insomnia, and headaches. Digestive symptoms such as dyspepsia, dry mouth, diarrhea, and constipation have also been reported. Tolerance to the effects of this medication can develop quickly, so if the effect diminishes, the dosage should not be increased but rather discontinued. Caution is needed when performing dangerous activities such as driving or operating machinery. Diabetic patients may need to adjust their insulin dosage. In cases of overdose, severe symptoms such as anxiety, coma, seizures, abnormal blood pressure, and vomiting may occur, requiring immediate emergency care. This medication should be kept out of the reach of children and is classified as a controlled substance with potential for abuse; thus, strict adherence to the physician's instructions is essential. Stopping the medication suddenly after long-term high-dose use may lead to severe fatigue and depression, so it should be discontinued gradually under medical guidance.
Hives
Palpitations, tachycardia, increased blood pressure, overactivity, anxiety, dizziness, insomnia, tremors, euphoria, headaches, psychiatric disorders at recommended doses, agitation, flushing, sweating, blurred vision, dry mouth, malaise, diarrhea, constipation, nausea, gastric pain, changes in sexual drive, frequent urination, urinary retention, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it is best kept at room temperature, not too hot or too cold.
White square tablet
30 tablets, 300 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPhendimetrazine Tartrate 17.5mg
Tablet · Prescription medication
Alvogen Korea Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Albuzene Korea Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Bionex Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.